Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

Oil Up, Fuel Demand Outlook Clears Over Full Vaccine Approval

Published 08/23/2021, 11:37 PM
Updated 08/23/2021, 11:42 PM
© Reuters.

By Gina Lee – Oil was up Tuesday morning in Asia, with the U.S. granting the first global full approval for a COVID-19 vaccine, and the expected boost in vaccination rates to follow, increasing hopes for higher fuel demand.

Brent oil futures edged up 0.12% to $68.45 by 11:32 PM ET (3:32 AM GMT) and WTI futures edged up 0.12% to $65.72. Both Brent and WTI futures jumped more than 5% on Monday after recording their biggest week of losses in more than nine months during the past week.

The FDA followed up the emergency use authorization it gave the Pfizer (NYSE:PFE) Inc/BioNTech SE two-dose vaccine in December 2020 with a full approval for use in those 16 and up.

Hopes are rising that the regulator’s approval will boost the U.S. vaccination drive by convincing unvaccinated Americans of the shot’s safety and efficacy. With more state and local governments, as well as private employers, likely to mandate vaccination, the aim is to boost economic recovery and re-openings, which will also boost fuel demand.

"Vaccine hesitancy across some minorities might end now that the FDA has given the all-clear signal. With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall," OANDA senior analyst Edward Moya told Reuters.

Investors now await U.S. crude oil supply data from the American Petroleum Institute, due later in the day. In India, the world’s third-largest oil importer, refiners' crude throughput in July hit its highest level in three months as rebounding fuel demand supported prices.

However, the black liquid’s gains were capped after the U.S. Department of Energy said on Monday that it would sell up to 20 million barrels of crude from the emergency oil reserve. The sales took place in order to comply with legislation passed in recent years, and deliveries are expected to take place between Oct. 1 and Dec. 15.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.